Articles > Popular publications > PR Newswire press releases > July-September 2000 > Tuesday, September 19

Article: STARLIX (NATEGLINIDE) RESTORES NATURAL INSULIN SECRETION PATTERNS IN PATIENTS WITH TYPE 2 DIABETES.

Article from:
PR Newswire
Article date:
September 19, 2000
Copyright

PRNewswire, London, September, 19. This release is transmitted on behalf of Novartis.

Rapid on-off action provides mealtime glucosspike contol wed overall insulin exposure and increased mealtime flexibility -

Jerusalem -- Starlix (nateglinide), an investigational stage drug for the treatment of type 2 diabetes, restores early phase insulin secretion following a meal without prolonging late stage secretion, according to data from two clinical studies presented at the European Association for the Study of Diabetes (EASD) meeting. This fast-on, fast-off action of Starlix mimics the body's natural insulin secretion pattern, which is lost in patients with ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: In New Studies Starlix(R) (Nateglinide) Enhanced Early ...
PR Newswire;  June 10, 2000 ;     700+ words ... ... earlier second phase insulin secretion and improved glucose ... hypoglycemia. Starlix Background Information ... indicate that Starlix has a rapid onset ... restore early phase insulin secretion and control mealtime ... of early phase insulin secretion is a ...

Article: Novartis Files New Drug Application For Starlix(R) ...
PR Newswire;  December 21, 1999 ;     700+ words ... ... diabetes is the loss of early insulin secretion in response to food. Starlix has a unique mechanism of action that can restore early insulin secretion and control mealtime glucose spikes. The ability of Starlix to mimic the body's natural ...

Article: Starlix improves glucose in people with prediabetes.
Diabetes Week;  July 22, 2002 ;     700+ words ... ... NewsRx.net) -- Starlix (nateglinide) enhances early insulin secretion and controls mealtime ... results showed that Starlix increased early insulin secretion with rapid onset ... restoring early insulin secretion with Starlix can slow progression ...

Article: FDA Approval for Starlix Received.
Drug Week;  January 19, 2001 ;     700+ words ... ... type 2 diabetes. Starlix works by stimulating ... short-acting insulin secretion. By this action, Starlix effectively lowers ... short-acting insulin secretion, addressing a ... In addition, Starlix does not cause ...

Article: FDA Approval for Starlix Received.(Novartis ...
Biotech Week;  January 17, 2001 ;     700+ words ... ... type 2 diabetes. Starlix works by stimulating ... short-acting insulin secretion. By this action, Starlix effectively lowers ... short-acting insulin secretion, addressing a ... In addition, Starlix does not cause ...

Article: Novartis Receives FDA Approval for Starlix, a New ...
Business Wire;  December 22, 2000 ;     700+ words ... ... type 2 diabetes. Starlix works by stimulating ... short-acting insulin secretion. By this action, Starlix effectively lowers ... short-acting insulin secretion, addressing a ... In addition, Starlix does not cause ...

Article: Novartis Receives FDA Approval For Starlix(R), A New ...
PR Newswire;  December 22, 2000 ;     700+ words ... ... type 2 diabetes. Starlix works by stimulating ... short-acting insulin secretion. By this action, Starlix effectively lowers ... short-acting insulin secretion, addressing a ... In addition, Starlix does not cause ...

Article: NOVARTIS RECEIVES EUROPEAN APPROVAL FOR STARLIX, FIRST IN ...
PR Newswire;  April 5, 2001 ;     700+ words ... ... infrequently. "Starlix stimulates early phase insulin secretion, the body's first ... sugar fluctuations, Starlix restores the body's natural early insulin secretion patterns, providing ... glucose spikes. Starlix also has a "fast ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives